Hope S. Rugo, MD, FAnnual Meeting, University of California, San Francisco shares the Trastuzumab-DKST has Regulatory Approval in US | 48-Week Survival & Safety of Monotherapy at Annual Meeting 2018
Trastuzumab-DKST has Regulatory Approval in US | 48-Week Survival & Safety of Monotherapy
